Nautilus Biotechnology
Nautilus Biotechnology develops the Voyager platform, which uses Iterative Mapping technology for accurate single-molecule quantification of proteins and proteoforms. Its products are designed for researchers in drug development, biomarker discovery, and exploratory biology to provide comprehensive views of the proteome and support deep biological insights. The organization aims to revolutionize biomedicine by unlocking the complexity of the proteome to positively impact global health.
Facts
- HQ
- Seattle
- Sectors
- Biotechnology Research
- Founded
- 2016
- Employees
- 148
- Stage
- Public
- Members see funding amounts. .
- Founders
- Sujal Patel, Parag Mallick, PhD
Is this your organization? Claim it
-
Signed a material agreement Sep 11, 2026
-
Leadership or executive-pay change Feb 27, 2025
-
Leadership or executive-pay change Jan 31, 2025
-
Signed a material agreement Feb 28, 2024
-
Leadership or executive-pay change Mar 31, 2022
-
Completed an acquisition or disposition Jun 10, 2021
-
Leadership or executive-pay change Jun 10, 2021
-
Signed a material agreement Feb 8, 2021
-
Signed a material agreement Aug 12, 2020
People
See all 4-
Sujal Patel Executive Officer, Director, Founder & CEO
-
Parag Mallick Founder & Chief Scientist
-
Anna Mowry Executive, Chief Financial Officer